Serum phosphorus, calcium, magnesium and potassium >= lower limit of normal (LLN)
Phosphorus >= LLN; NOTE: Supplementation may be given before the first dose of study medication
Serum phosphorus >= lower limit of normal (LLN)
Serum phosphorus >= 2.3 and < 4.8 mg/dL
Serum phosphorus within normal institutional limits
Phosphorus WNL
Demonstrate adequate organ function as defined in protocol, AND normal (WNL of local lab range) serum correct calcium, and phosphorus levels.
Phosphorus =< institutional upper limit of normal
Within 7 days before the first dose of study treatment: Serum phosphorus, calcium, magnesium and potassium >= lower limit of normal (LLN)
Serum calcium & phosphorus within normal institutional limits
Use of medications that increase serum levels of phosphorus and/or calcium
Inorganic phosphorus outside of normal limits
Serum phosphorus >= lower limit of normal (LLN)
Serum phosphorus >= lower limit of normal (LLN)
Phosphorus < LLN
Normal phosphorus (can be on oral supplementation)
Phosphorus >= 2.3 mg/dL
RENAL COHORT: Laboratory values as follows within 4 days before the first dose of daratumumab: serum phosphorus ? lower limit of normal (LLN)
Phosphorus >= LLN =< 14 days prior to registration\r\n* NOTE: Supplementation may be given before the first dose of study medication
Serum phosphorus, calcium, magnesium and potassium >= lower limit of normal (LLN)
Serum phosphorus >= lower limit of normal
Phosphorus above lower limit normal range for the institution; supplementation may be given before the first dose of study medication
Serum phosphorus >= lower limit of normal (LLN)
Serum phosphorus, calcium and potassium >= lower limit of normal (LLN)
Obtained =< 7 days prior to registration: Phosphorus WNL
Serum phosphorus >= LLN
Serum phosphorus >= lower limit of normal (LLN)
Serum phosphorus >= lower limits of normal (LLN)
Serum phosphorus >= lower limit of normal (LLN)
Serum potassium, magnesium and phosphorus >= lower limit of normal (LLN) and =< 1.2 x ULN
Serum phosphorus, magnesium, calcium and potassium >= lower limit of normal (LLN)
Serum phosphorus >= lower limit of normal (LLN) (if below LLN, for asymptomatic patients replacement may be initiated if clinically indicated without delaying the start of study treatment)
Serum phosphorus >= LLN
Serum phosphorus > 2.5; electrolyte repletion is allowed to reach these values
Use of medications that increase serum levels of phosphorus and/or calcium
Inorganic phosphorus outside of normal limits
Sodium, potassium, and phosphorus levels no worse than grade 1
Serum phosphorus >= LLN
Serum phosphorus calcium, magnesium and potassium >= lower limit of normal (LLN)
Serum phosphorus, magnesium, and potassium >= lower limit of normal (LLN) after adequate supplementation if necessary
Phosphorus >= institutional lower limit of normal (repletion allowed)
Normal serum electrolytes, magnesium and phosphorus on the day of therapy; correction of abnormalities is permitted
Calcium phosphorus product less than 4.0mmol2/L2.
Inorganic phosphorus =< ULN
Phosphorus less than 4.0 times below or above the upper or lower limit range